Acute toxicity and genotoxicity studies on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanomaterials

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 696, Issue 2, 2010, Pages 101-106

  Huang, Yina ^a,b   Gao, Hong ^b   Gou, Maling ^a   Ye, Huaxia ^b   Liu, Yunke ^b   Gao, Yuan ^b   Peng, Feng ^a   Qian, Zhiyong ^a   Cen, Xiaobo ^a   Zhao, Yinglan ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Acute toxicity; Genotoxicity; Nanomaterials; Poly( caprolactone) poly(ethylene glycol) poly( caprolactone)

Indexed keywords

MACROGOL; NANOMATERIAL; POLYCAPROLACTONE;

ACUTE TOXICITY; AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; CHINESE HAMSTER; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE; FEMALE; GENOTOXICITY; LD 50; LUNG ALVEOLUS CELL; MALE; METABOLIC ACTIVATION; MICRONUCLEUS TEST; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA TYPHIMURIUM; SOLVENT EXTRACTION;

ANIMALS; DRUG CARRIERS; FEMALE; MALE; MUTAGENICITY TESTS; MUTAGENS; NANOSTRUCTURES; POLYESTERS; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY;

BACTERIA (MICROORGANISMS); CRICETULUS GRISEUS; MUS; RATTUS; SALMONELLA TYPHIMURIUM;

EID: 77549083607     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2009.12.016     Document Type: Article

References (26)

1. Moghimi S.M., Hunter A.C., and Murray J.C. Nanomedicine: current status and future prospects. FASEB J. 19 (2005) 311-330
2. Dong Y.C., and Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 25 (2004) 2843-2849
3. Fonseca C., Simes S., and Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J. Control. Release 83 (2002) 273-286
4. Hu Y., Xie J.W., Tong Y.W., and Wang G.H. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J. Control. Release 118 (2007) 7-17
5. Zalfen A.M., Nizet D., Jerome C., Frankenne F., Foidart J.M., Maquet V., Lecomte F., Hubert P., and Evrard B. Controlled release of drugs from multi-component biomaterials. Acta Biomater. 4 (2008) 1788-1796
6. Zhou S.B., Deng X.M., and Yang H. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials 24 (2003) 3563-3570
7. Jia W.J., Gu Y.C., Gou M.L., Dai M., Li X.Y., Kan B., Yang J.L., Song Q.F., Wei Y.Q., and Qian Z.Y. Preparation of biodegradable polycaprolactone/poly (ethylene glycol)/polycaprolactone (PCEC) nanoparticles. Drug Deliv. 15 (2008) 409-416
8. Huang M.J., Gou M.L., Qian Z.Y., Dai M., Li X.Y., Cao M., Wang K., Zhao J., Yang J.L., Lu Y., Tu M.J., and Wei Y.Q. One-step preparation of poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles for plasmid DNA delivery. J. Biomed. Mater. Res. A 86 (2008) 979-986
9. Gou M.L., Huang M.J., Qian Z.Y., Dai M., Li X.Y., and Wei Y.Q. Preparation of anionic poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) copolymeric nanoparticles as basic protein antigen carrier. Growth Factors 25 (2007) 202-208
10. Gou M.L., Dai M., Li X.Y., Yang L., Huang M.J., Wang Y.S., Kan B., Lu Y., Wei Y.Q., and Qian Z.Y. Preparation of mannan modified anionic PCL-PEG-PCL nanoparticles at one-step for bFGF antigen delivery to improve humoral immunity. Colloid Surf. B - Biointerfaces 64 (2008) 135-139
11. Gou M.L., Li X.Y., Dai M., Gong C.Y., Wang X.H., Xie Y., Deng H.X., Chen L.J., Zhao X., Qian Z.Y., and Wei Y.Q. A novel injectable local hydrophobic drug delivery system: biodegradable nanoparticles in thermo-sensitive hydrogel. Int. J. Pharm. 359 (2008) 228-233
12. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., and Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 150 (2007) 552-558
13. Norppa H., and Greim H. Conclusions and outlook. Toxicol. Lett. 186 (2009) 174-175
14. Kabanov A.V. Polymer genomics: an insight into pharmacology and toxicology of nanomedicines. Adv. Drug Deliv. Rev. 58 (2006) 1597-1621
15. Gou M.L., Zheng X.L., Men K., Zhang J., Zhang L., Wang X.H., Luo F., Zhao Y.L., Zhao X., Wei Y.Q., and Qian Z.Y. Poly(ε-caprolactone)/Poly(ethylene glycol)/Poly(ε-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery. J. Phys. Chem. B 113 (2009) 12928-12933
16. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
17. Ishidate J.M., and Yoshikawa K. Chromosome aberration tests with Chinese hamster cells in vitro with and without metabolic activation: a comparative study on mutagens and carcinogens. Arch. Toxicol. Suppl. 4 (1980) 41-44
18. Hayashi M., Sofuni T., and Ishidate J.M. An application of acridine orange fluorescent staining to the micronucleus test. Mutat. Res. 120 (1983) 241-247
19. Kim S.Y., Lee Y.M., Baik D.J., and Kang J.S. Toxic characteristics of methoxy poly(ethylene glycol)/poly(ε-caprolactone) nanospheres in vitro and in vivo studies in the normal mice. Biomaterials 24 (2003) 55-63
20. Fang F., Gong C.Y., Dong P.W., Fu S.Z., Gu Y.C., Guo G., Zhao X., Wei Y.Q., and Qian Z.Y. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer. Biomed. Mater. 4 (2009) 025002
21. Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of triethylene glycol and PEG-4. Int. J. Toxicol. 25 Suppl 2 (2006) 121-138
22. Ali A.Q., Kannan T.P., Ahmad A., and Samsudin A.R. In vitro genotoxicity tests for polyhydroxybutyrate - a synthetic biomaterial. Toxicol. in Vitro 22 (2008) 57-67
23. R. Landsiedel, M.D. Kapp, M. Schulz, K. Wiench, F. Oesch, Genotoxicity investigations on nanomaterials: Methods, preparation and characterization of test material, potential artifacts and limitations - Many questions, some answers. Mutat. Res. Rev. Mutat. Res. 681 (2009) 241-258.
24. Nakagawa Y., Wakuri S., Sakamoto K., and Tanaka N. The photogenotoxicity of titanium dioxide particles. Mutat. Res. 394 (1997) 125-132
25. 2 particles as a component of nanoparticle risk management. Toxicol. Lett. 171 (2007) 99-110
26. Amaral A.C., Bocca A.L., Ribeiro A.M., Nunes J., Peixoto D.L.G., Simioni A.R., Primo F.L., Lacava Z.G.M., Bentes R., Titze-de-Almeida R., Tedesco A.C., Morais P.C., and Felipe M.S.S. Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis. J. Antimicrob. Chemother. 63 (2009) 526-533